BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28213091)

  • 1. Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity.
    Fader KA; Nault R; Kirby MP; Markous G; Matthews J; Zacharewski TR
    Toxicol Appl Pharmacol; 2017 Apr; 321():1-17. PubMed ID: 28213091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of the AH receptor in the dysfunction of heme metabolism induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Davies R; Clothier B; Robinson SW; Edwards RE; Greaves P; Luo J; Gant TW; Chernova T; Smith AG
    Chem Res Toxicol; 2008 Feb; 21(2):330-40. PubMed ID: 18163543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
    Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-
    Fling RR; Zacharewski TR
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters hepatic polyunsaturated fatty acid metabolism and eicosanoid biosynthesis in female Sprague-Dawley rats.
    Doskey CM; Fader KA; Nault R; Lydic T; Matthews J; Potter D; Sharratt B; Williams K; Zacharewski T
    Toxicol Appl Pharmacol; 2020 Jul; 398():115034. PubMed ID: 32387183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis.
    Angrish MM; Jones AD; Harkema JR; Zacharewski TR
    Toxicol Sci; 2011 Dec; 124(2):299-310. PubMed ID: 21890736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin.
    Nault R; Fader KA; Lydic TA; Zacharewski TR
    Chem Res Toxicol; 2017 Apr; 30(4):1060-1075. PubMed ID: 28238261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate Kinase Isoform Switching and Hepatic Metabolic Reprogramming by the Environmental Contaminant 2,3,7,8-Tetrachlorodibenzo-p-Dioxin.
    Nault R; Fader KA; Kirby MP; Ahmed S; Matthews J; Jones AD; Lunt SY; Zacharewski TR
    Toxicol Sci; 2016 Feb; 149(2):358-71. PubMed ID: 26582802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis.
    Nault R; Fader KA; Ammendolia DA; Dornbos P; Potter D; Sharratt B; Kumagai K; Harkema JR; Lunt SY; Matthews J; Zacharewski T
    Toxicol Sci; 2016 Dec; 154(2):253-266. PubMed ID: 27562557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity.
    Boverhof DR; Burgoon LD; Tashiro C; Chittim B; Harkema JR; Jump DB; Zacharewski TR
    Toxicol Sci; 2005 Jun; 85(2):1048-63. PubMed ID: 15800033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin.
    Pierre S; Chevallier A; Teixeira-Clerc F; Ambolet-Camoit A; Bui LC; Bats AS; Fournet JC; Fernandez-Salguero P; Aggerbeck M; Lotersztajn S; Barouki R; Coumoul X
    Toxicol Sci; 2014 Jan; 137(1):114-24. PubMed ID: 24154488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver.
    Sato S; Shirakawa H; Tomita S; Ohsaki Y; Haketa K; Tooi O; Santo N; Tohkin M; Furukawa Y; Gonzalez FJ; Komai M
    Toxicol Appl Pharmacol; 2008 May; 229(1):10-9. PubMed ID: 18295293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on heme oxygenase-1, biliverdin IXalpha reductase and delta-aminolevulinic acid synthetase 1 in rats with wild-type or variant AH receptor.
    Niittynen M; Tuomisto JT; Pohjanvirta R
    Toxicology; 2008 Sep; 250(2-3):132-42. PubMed ID: 18657588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chimeric aryl hydrocarbon receptor knockout mouse model indicates that aryl hydrocarbon receptor activation in hematopoietic cells contributes to the hepatic lesions induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin.
    Thurmond TS; Silverstone AE; Baggs RB; Quimby FW; Staples JE; Gasiewicz TA
    Toxicol Appl Pharmacol; 1999 Jul; 158(1):33-40. PubMed ID: 10387930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCDD-elicited effects on liver, serum, and adipose lipid composition in C57BL/6 mice.
    Angrish MM; Dominici CY; Zacharewski TR
    Toxicol Sci; 2013 Jan; 131(1):108-15. PubMed ID: 22977169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon receptor-dependent induction of loss of mitochondrial membrane potential in epididydimal spermatozoa by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Fisher MT; Nagarkatti M; Nagarkatti PS
    Toxicol Lett; 2005 Jun; 157(2):99-107. PubMed ID: 15836997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl hydrocarbon receptor knockout rats are insensitive to the pathological effects of repeated oral exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Harrill JA; Layko D; Nyska A; Hukkanen RR; Manno RA; Grassetti A; Lawson M; Martin G; Budinsky RA; Rowlands JC; Thomas RS
    J Appl Toxicol; 2016 Jun; 36(6):802-14. PubMed ID: 26278112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between iron metabolism and 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice with variants of the Ahr gene: a hepatic oxidative mechanism.
    Smith AG; Clothier B; Robinson S; Scullion MJ; Carthew P; Edwards R; Luo J; Lim CK; Toledano M
    Mol Pharmacol; 1998 Jan; 53(1):52-61. PubMed ID: 9443932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.
    Fader KA; Nault R; Raehtz S; McCabe LR; Zacharewski TR
    Toxicol Appl Pharmacol; 2018 Jun; 348():85-98. PubMed ID: 29673856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice.
    Fader KA; Nault R; Ammendolia DA; Harkema JR; Williams KJ; Crawford RB; Kaminski NE; Potter D; Sharratt B; Zacharewski TR
    Toxicol Sci; 2015 Dec; 148(2):567-80. PubMed ID: 26377647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.